Terpenoid ID | TKC018288 |
![]() |
Cell line | 0 | |
Protein target | 14 | |
DiseaseNCIT | 0 | |
ORDO | 0 | |
ICD | 30 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|---|---|---|---|---|---|---|
TKC018288 | HepG2 | 14125.0 | nM | Potency | C3728 | Orphanet_449 |
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC018288 | O95398 | Rap guanine nucleotide exchange factor 3 | RAPGEF3 | 44668 | nM | Potency |
TKC018288 | P43220 | Glucagon-like peptide 1 receptor | GLP1R | 11220 | nM | Potency |
TKC018288 | P53350 | Serine/threonine-protein kinase PLK1 | PLK1 | 13371 | nM | Potency |
TKC018288 | P84022 | Mothers against decapentaplegic homolog 3 | SMAD3 | 22387 | nM | Potency |
TKC018288 | Q14191 | Werner syndrome ATP-dependent helicase | WRN | 63096 | nM | Potency |
TKC018288 | P27695 | DNA-(apurinic or apyrimidinic site) endonuclease | APEX1 | 7943 | nM | Potency |
TKC018288 | O75496 | Geminin | GMNN | 5174 | nM | Potency |
TKC018288 | P01215 | Glycoprotein hormones alpha chain | CGA | 316 | nM | Potency |
TKC018288 | O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | USP1 | 44668 | nM | Potency |
TKC018288 | P39748 | Flap endonuclease 1 | FEN1 | 89125 | nM | Potency |
TKC018288 | Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | PIN1 | 28184 | nM | Potency |
TKC018288 | P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | HPGD | 28184 | nM | Potency |
TKC018288 | Q9Y253 | DNA polymerase eta | POLH | 89125 | nM | Potency |
TKC018288 | Q8WZA2 | Rap guanine nucleotide exchange factor 4 | RAPGEF4 | 31623 | nM | Potency |
TKC018288 | P17861 | X-box-binding protein 1 | XBP1 | >10000 | nM | IC50 |
TKC018288 | P35639 | DNA damage-inducible transcript 3 protein | Ddit3 | >9680 | nM | IC50 |
TKC018288 | P35639 | DNA damage-inducible transcript 3 protein | Ddit3 | >10000 | nM | IC50 |
Uniport ID | Uniport Name | ICD-11 |
---|---|---|
O95398 | RPGF3_HUMAN | Epidermal dysplasias [ICD-11: EK90] |
P43220 | GLP1R_HUMAN | Cardiovascular disease [ICD-11: BA00-BE2Z] |
P43220 | GLP1R_HUMAN | Obesity [ICD-11: 5B80-5B81] |
P43220 | GLP1R_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
P43220 | GLP1R_HUMAN | Type-1/2 diabete [ICD-11: 5A10-5A11] |
P43220 | GLP1R_HUMAN | Acute diabete complication [ICD-11: 5A2Y] |
P43220 | GLP1R_HUMAN | Diabetes mellitus [ICD-11: 5A10] |
P43220 | GLP1R_HUMAN | Dyspepsia [ICD-11: MD92] |
P43220 | GLP1R_HUMAN | Irritable bowel syndrome [ICD-11: DD91] |
P43220 | GLP1R_HUMAN | Intracranial injury [ICD-11: NA07] |
P43220 | GLP1R_HUMAN | Non-alcoholic fatty liver disease [ICD-11: DB92] |
P53350 | PLK1_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
P53350 | PLK1_HUMAN | Myelodysplastic syndrome [ICD-11: 2A37] |
P53350 | PLK1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P53350 | PLK1_HUMAN | Prostate cancer [ICD-11: 2C82] |
P53350 | PLK1_HUMAN | Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P53350 | PLK1_HUMAN | Pancreatic cancer [ICD-11: 2C10] |
P53350 | PLK1_HUMAN | Lymphoma [ICD-11: 2A80-2A86] |
P53350 | PLK1_HUMAN | Nasopharyngeal cancer [ICD-11: 2B6B] |
P53350 | PLK1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P84022 | SMAD3_HUMAN | Herpes simplex infection [ICD-11: 1F00] |
P84022 | SMAD3_HUMAN | Kidney fibrosis [ICD-11: GC01] |
Q14191 | WRN_HUMAN | Mature T-cell lymphoma [ICD-11: 2A90] |
P27695 | APEX1_HUMAN | Retinopathy [ICD-11: 9B71] |
P27695 | APEX1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P27695 | APEX1_HUMAN | Ocular cancer [ICD-11: 2D00-2D07] |
P27695 | APEX1_HUMAN | Brain cancer [ICD-11: 2A00] |
P27695 | APEX1_HUMAN | Melanoma [ICD-11: 2C30] |
O94782 | UBP1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q13526 | PIN1_HUMAN | Lung cancer [ICD-11: 2C25] |
Q13526 | PIN1_HUMAN | Nasopharyngeal cancer [ICD-11: 2B6B] |